Início › Câncer de Ovário › Carolina do Norte
Ensaios clínicos de Câncer de Ovário em Carolina do Norte
44 estudos para Câncer de Ovário estão buscando participantes em locais em Carolina do Norte.
Cidades em Carolina do Norte
Texto oficial do estudo (Inglês)
The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
RecrutandoVoluntários saudáveis bem-vindos
Idades de 45 a 75 · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06995898Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- University of North Carolina-Hillsborough Campus, Hillsborough
- Wake Forest University Health Sciences, Winston-Salem
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- Southeastern Medical Oncology Center-Clinton, Clinton
- e mais 9
RecrutandoFase 2
Todas as idades · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05564377A Study of PHST001 in Advanced Solid Tumors
- Duke Cancer Institute, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Carolina Cancer Research Center, Wilson
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
RecrutandoFase 1/2
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07360314A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- University of North Carolina Medical Center /ID# 275307, Chapel Hill
- Atrium Health Levine Cancer Institute /ID# 274557, Charlotte
- East Carolina University - Brody School of Medicine /ID# 275770, Greenville
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT06890338A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Site 0259 - Duke Cancer Center, Durham
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05128825DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Duke Cancer Institute, Durham
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213804A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Duke University Medical Center, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- FirstHealth of the Carolinas- Speciality Center /ID# 278636, Pinehurst
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 22 de set. de 2026 · NCT07059845A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Duke Cancer Center ( Site 0012), Durham
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Levine Cancer Center, Charlotte
- Novant Presbyterian Hospital, Charlotte
- East Carolina University, Greenville
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 15 de set. de 2026 · NCT07214779ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UNC- Chapel Hill, Chapel Hill
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- Duke, Durham
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 14 de set. de 2026 · NCT04575935A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Charlotte
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- FirstHealth Cancer Center ( Site 0079), Pinehurst
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06824467Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Levine Cancer Institute, Charlotte
- East Carolina University, Greenville
- Atrium Health Wake Forest Baptist, Comprehensive Cancer Center, Winston-Salem
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 26 de ago. de 2026 · NCT05281471A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- Atrium Health - Wake Forest, Charlotte
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Mission Hospital, Asheville
- Hope Women's Cancer Centers-Asheville, Asheville
- Duke Cancer Center Cary, Cary
- e mais 7
Recrutando
Idades de 35 a 50 · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04251052A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06751329Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Duke University Medical Center, Durham
- Duke Women's Cancer Care Raleigh, Raleigh
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06580314A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07749586A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
RecrutandoFase 2
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797The Better, Harder, Faster, Stronger Study
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RecrutandoEstudo observacional
Idades 55 e acima · Mulheres · Atualizado em 15 de jul. de 2026 · NCT07220512CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
- Duke University, Durham
RecrutandoFase 1/2
Idades de 18 a 75 · Mulheres · Atualizado em 13 de jul. de 2026 · NCT07322094Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- UNC Hospital, Chapel Hill
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 2 de jul. de 2026 · NCT06819007Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- GSK Investigational Site, Charlotte
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jun. de 2026 · NCT04641247Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Carolina BioOncology Institute, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT06993844Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
- Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 19 de mai. de 2026 · NCT06305299Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Duke Cancer Center, Durham
- Duke Women's Cancer Care Raleigh, Raleigh
RecrutandoFase 3
Idades 18 e acima · Mulheres · Atualizado em 16 de abr. de 2026 · NCT05659381REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
- Duke Cancer Center, Durham
Recrutando
Idades 18 e acima · Mulheres · Atualizado em 13 de abr. de 2026 · NCT06710548A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
- Site 0259, Durham
RecrutandoFase 1
Idades 18 e acima · Mulheres · Atualizado em 7 de abr. de 2026 · NCT04516447TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Duke University Hospital, Durham
Recrutando
Idades de 25 a 50 · Mulheres · Atualizado em 6 de abr. de 2026 · NCT04294927Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
- Duke Cancer Center/ DUMC, Durham
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de abr. de 2026 · NCT05735080A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Duke Cancer Institute, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.